Bioprinting Technologies and Global Markets Report 2023 Featuring Leading Players - 3D Bio, Advanced Solutions, Cellink, Organovo, and Stratasys - ResearchAndMarkets.com
19 Jan 2023
DUBLIN--(BUSINESS WIRE)--The "Bioprinting: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
This report incorporates an in-depth analysis of the bioprinting market, including market estimations and trends through 2020. Major players, competitive intelligence, innovative technologies, market dynamics, and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players.
The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for bioprinting technologies.
The use of technology in medical devices impacts multiple therapeutic areas. The most significant user segments include tissue engineering, drug discovery, and regenerative medicine. As per the WHO, 21 patients per day die due to organ transplant shortages. Bioprinted organs could help clinicians and patients to eliminate the list of requirements of organs. The technology has been used as one of the most impactful possibilities in the field.
Laser bioprinting is growing at a high rate due to its advantages in high print speeds, high cell densities, good cell viability, and higher resolution patterns. Also, since there is no nozzle, there are no issues with a nozzle clogging with cells or other materials during printing.
The main advantages of the photopolymerization technique is achieving covalently crosslinked hydrogels, helping to drive the use and growth of these bioprinters. Advantages include the ability to print high-viscosity biomaterials, creation of large constructs, high cell densities, sterile environments, and affordability.
The scope of the report extends to only those bioprinting technologies that generate the most global revenue. Surgical device or guides and ceramics or metal devices used in 3D bioprinting overlap with other products that are already covered under the technology segments, so these have been excluded.
This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World region. For market estimates, data is provided for 2020, as the base year 2021 and forecast through year-end 2027.
Report Includes
26 data tables and 35 additional tables
An up-to-date review and analysis of the global markets for bioprinting technologies and applications within the industry
Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of market opportunities for this innovation-driven market, and the major regions and countries involved in market developments
Estimation of the actual market size and revenue forecast for global bioprinting market in USD millions, and corresponding market share analysis by type of technology, application, end-user, and region
Technology assessment of the key drivers, restraints and opportunities that will shape the market for bioprinting over the forecast period (2022 to 2027)
Analysis of the markets for the main bioprinting end-use applications, including research, drug discovery and development, cosmetics, and clinical
Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on technologies, applications, and end users of bioprinting
Updated information on recent industry acquisitions, partnerships, agreements, collaborations, and other strategic alliances in the global bioprinting market
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Profile descriptions of the market leading participants, including 3D Bio Corp., Advanced Solutions Inc., Cellink, Organovo, and Stratasys Ltd.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Bioprinting Product Life Cycle
3.2 Bioprinting Industry
3.3 Bioprinting Instrument Technologies
3.3.1 Software
3.3.2 Organ-On-Chip
3.4 Organs and Organoids
3.4.1 Organoids
3.4.2 Organs
3.5 Technological Challenges in Printing Organs
3.6 Bioprinting Applications
3.7 Innovations in Medical/Healthcare Products
3.7.1 Diagnosing Diseases
3.7.2 Monitoring Patients
3.7.3 Personalized Medicine
3.8 Current Trends
3.8.1 Enhanced Cybersecurity
3.8.2 Internet of Medical Things (Iomt)
3.8.3 Medical Robots
3.8.4 3D Printed Objects
3.8.5 Device Connectivity
3.9 Regulations and Legislation
3.9.1 Europe
3.9.2 U.S.
3.9.3 Japan
Chapter 4 Market Dynamics
4.1 Market Dynamics
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Strategies
4.1.5 Trends
Chapter 5 Impact of the Covid-19 Pandemic
5.1 Impact of Covid-19 on the Market for Bioprinting
5.1.1 Personal Protective Equipment (Ppe)
5.1.2 Face Masks
5.1.3 Face Shields
5.1.4 3D Printing in Healthcare
Chapter 6 Global Market for Bioprinting Technologies
6.1 Overview
6.2 Droplet Disposition
6.2.1 Market Outlook
6.3 Photopolymerization
6.3.1 Market Outlook
Chapter 7 Global Market for Bioprinting End Uses
7.1 Overview
7.2 Drug Discovery and Development
7.2.1 Market Outlook
7.3 Research
7.4 Cosmetics
7.5 Other End Uses
Chapter 8 Global Market for Bioprinting Technologies by Region
8.1 Overview
8.2 North America
8.2.1 Market Outlook
8.3 Europe
8.3.1 Market Outlook
8.4 Asia-Pacific
8.4.1 Market Outlook
8.5 Rest of the World
8.5.1 Market Outlook
Chapter 9 Competitive Landscape
Chapter 10 Company Profiles
Cellink
Stratasys Ltd
For more information about this report visit https://www.researchandmarkets.com/r/mi72g5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.